S. Bindoli

发表

Regulation of crystal induced inflammation: current understandings and clinical implications

R. Ramonda, A. Scanu, P. Galozzi, 2021, Expert review of clinical immunology.

The revisited role of interleukin-1 alpha and beta in autoimmune and inflammatory disorders and in comorbidities.

A. Doria, P. Sfriso, S. Bindoli, 2021, Autoimmunity reviews.

18F-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography With Magnetic Resonance for Diagnosing Adult-Onset Still's Disease

C. Campi, L. Rubin, A. Doria, 2020, Frontiers in Medicine.

The amount of cytokine-release defines different shades of Sars-Cov2 infection

A. Doria, M. Felicetti, P. Sfriso, 2020, Experimental biology and medicine.

Progress in Biological Therapies for Adult-Onset Still’s Disease

A. Doria, P. Galozzi, P. Sfriso, 2022, Biologics : targets & therapy.

BTT_A_290329 21..34

A. Doria, P. Galozzi, P. Sfriso, 2022 .

Adult-Onset Still’s Disease: Molecular Pathophysiology and Therapeutic Advances

P. Galozzi, P. Sfriso, S. Bindoli, 2018, Drugs.

Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still’s Disease: A Multicentre Retrospective Observational Study

L. Punzi, G. Cavalli, E. Baldissera, 2017, Front. Pharmacol..

A Pro-Inflammatory Signature Constitutively Activated in Monogenic Autoinflammatory Diseases

P. Tighe, O. Negm, L. Punzi, 2022, International journal of molecular sciences.

Development and Role in Therapy of Canakinumab in Adult-Onset Still’s Disease

P. Galozzi, F. Oliviero, P. Sfriso, 2018, Front. Pharmacol..

Autoinflammatory Mechanisms in Crystal-Induced Arthritis

A. Doria, E. Feist, A. Scanu, 2020, Frontiers in Medicine.

Belimumab: a step forward in the treatment of systemic lupus erythematosus

M. Gatto, L. Iaccarino, A. Doria, 2021, Expert opinion on biological therapy.

SARS-CoV-2 infection in patients with autoimmune rheumatic diseases in northeast Italy: A cross-sectional study on 916 patients

M. Gatto, L. Iaccarino, A. Doria, 2020, Journal of Autoimmunity.

Hyperinflammation after anti-SARS-CoV-2 mRNA/DNA vaccines successfully treated with anakinra: Case series and literature review

A. Doria, P. Galozzi, P. Sfriso, 2022, Experimental biology and medicine.

Sarcoidosis and Autoimmunity: From Genetic Background to Environmental Factors.

Y. Shoenfeld, A. Doria, C. Perricone, 2016, The Israel Medical Association journal : IMAJ.

New onset and flare of rheumatic diseases following COVID-19 vaccination are mild and respond well to treatment: 9-month follow-up data from a single centre cohort.

M. Gatto, L. Iaccarino, A. Doria, 2021, Clinical and experimental rheumatology.

Autoinflammatory Features in Gouty Arthritis

A. Doria, P. Galozzi, F. Oliviero, 2021, Journal of clinical medicine.

Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

F. Montagnini, M. Giacomini, G. Innocenti, 2020, Journal of Translational Medicine.

Canakinumab for the treatment of adult-onset Still’s disease

A. Doria, E. Feist, P. Galozzi, 2020, Expert review of clinical immunology.

Osteoporosis in Systemic Autoinflammatory Diseases: A Case-Control Study

P. Galozzi, M. Zaninotto, P. Sfriso, 2019, Frontiers in Endocrinology.

Intravenous anakinra to curb cytokine storm in adult-onset Still's disease and in macrophage activation syndrome: A case series

A. Doria, P. Galozzi, P. Sfriso, 2023, Joint Bone Spine.

IL-18 in Autoinflammatory Diseases: Focus on Adult Onset Still Disease and Macrophages Activation Syndrome

A. Doria, F. Oliviero, P. Sfriso, 2023, International journal of molecular sciences.

JAK inhibitors for the treatment of VEXAS syndrome

P. Sfriso, E. Bertoldo, S. Bindoli, 2023, Experimental biology and medicine.

Adult-Onset Still’s Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options

P. Sfriso, S. Bindoli, Andrea Doria, 2024, Drugs.

Pulmonary alveolar proteinosis in an adult patient affected by Still's disease and recurrent episodes of macrophage activation syndrome.

P. Sfriso, S. Bindoli, Fiorella Calabrese, 2023, Joint bone spine.

Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry

A. Iagnocco, B. Ogunjimi, C. Campochiaro, 2023, Internal and Emergency Medicine.

Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry.

A. Tomelleri, C. Campochiaro, L. Dagna, 2024, Seminars in arthritis and rheumatism.

Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort

M. Voso, A. Tomelleri, C. Campochiaro, 2023, American journal of hematology.

Autoinflammatory Diseases and COVID-19 Vaccination: Analysis of SARS-CoV-2 Anti-S-RBD IgG Levels in a Cohort of Patients Receiving IL-1 Inhibitors

C. Cosma, P. Galozzi, P. Sfriso, 2023, Journal of clinical medicine.

Efficacy and safety of therapies for Still's disease and macrophage activation syndrome (MAS): a systematic review informing the EULAR/PReS guidelines for the management of Still's disease.

S. Mitrovic, S. Bindoli, Fabrizio de Benedetti, 2024, Annals of the rheumatic diseases.